SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-130371
Filing Date
2023-05-01
Accepted
2023-05-01 16:03:58
Documents
10
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d435988ddef14a.htm DEF 14A 581324
2 GRAPHIC g435988dsp001.jpg GRAPHIC 148732
3 GRAPHIC g435988dsp002.jpg GRAPHIC 72686
4 GRAPHIC g435988g16f01.jpg GRAPHIC 46923
5 GRAPHIC g435988g16t02.jpg GRAPHIC 45815
6 GRAPHIC g435988g16w03.jpg GRAPHIC 52149
7 GRAPHIC g435988g43d02.jpg GRAPHIC 57099
8 GRAPHIC g435988g43n02.jpg GRAPHIC 23614
9 GRAPHIC g435988g43n40.jpg GRAPHIC 23614
10 GRAPHIC g435988g43t04.jpg GRAPHIC 56624
  Complete submission text file 0001193125-23-130371.txt   1294541
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39692 | Film No.: 23873494
SIC: 2836 Biological Products, (No Diagnostic Substances)